CLSN logo

Imunon (CLSN) Return On Equity

Annual ROE

-55.83%
+73.71%+56.90%

December 31, 2021


Summary


Performance

CLSN ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCLSNprofitabilitymetrics:

Quarterly ROE

-53.82%
-5.84%-12.17%

September 30, 2022


Summary


Performance

CLSN Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCLSNprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

CLSN ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+56.9%-18.6%
3 y3 years-11.7%-19.4%
5 y5 years+54.3%+82.0%

CLSN ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low+31.0%at low
5 y5-yearat high+132.0%+31.0%+125.0%
alltimeall time-121.7%>+9999.0%-106.5%+5198.8%

Imunon ROE History

DateAnnualQuarterly
Sep 2022
-
-53.82%(+12.2%)
Jun 2022
-
-47.98%(+5.3%)
Mar 2022
-
-45.57%(+10.9%)
Dec 2021
-55.83%(-56.9%)
-41.08%(-9.4%)
Sep 2021
-
-45.36%(-26.3%)
Jun 2021
-
-61.56%(-26.2%)
Mar 2021
-
-83.36%(-28.4%)
Dec 2020
-129.54%(+36.1%)
-116.45%(-3.8%)
Sep 2020
-
-121.08%(+13.9%)
Jun 2020
-
-106.31%(-5.9%)
Mar 2020
-
-113.01%(+22.2%)
Dec 2019
-95.15%(+90.4%)
-92.48%(+105.1%)
Sep 2019
-
-45.09%(+15.5%)
Jun 2019
-
-39.05%(-20.0%)
Mar 2019
-
-48.80%(-13.4%)
Dec 2018
-49.97%(-59.1%)
-56.34%(-54.1%)
Sep 2018
-
-122.63%(-13.4%)
Jun 2018
-
-141.65%(-1.8%)
Mar 2018
-
-144.24%(-27.2%)
Dec 2017
-122.06%(-25.0%)
-198.19%(-33.7%)
Sep 2017
-
-298.78%(+27.3%)
Jun 2017
-
-234.69%(+20.6%)
Mar 2017
-
-194.63%(+22.7%)
Dec 2016
-162.69%(+92.7%)
-158.65%(+25.7%)
Sep 2016
-
-126.17%(+34.1%)
Jun 2016
-
-94.12%(+3.7%)
Mar 2016
-
-90.80%(+8.4%)
Dec 2015
-84.42%(+6.5%)
-83.75%(+9.2%)
Sep 2015
-
-76.66%(+1.7%)
Jun 2015
-
-75.41%(+2.7%)
Mar 2015
-
-73.43%(+9.0%)
Dec 2014
-79.24%(+108.8%)
-67.38%(+8.7%)
Sep 2014
-
-61.96%(+10.6%)
Jun 2014
-
-56.01%(+43.2%)
Mar 2014
-
-39.10%(+30.7%)
Dec 2013
-37.95%(-72.7%)
-29.91%(-43.1%)
Sep 2013
-
-52.59%(-24.0%)
Jun 2013
-
-69.18%(-39.3%)
Mar 2013
-
-114.03%(-26.1%)
Dec 2012
-139.26%(-35.2%)
-154.26%(+16.7%)
Sep 2012
-
-132.18%(-14.9%)
Jun 2012
-
-155.27%(-27.0%)
Mar 2012
-
-212.78%(-35.3%)
Dec 2011
-214.85%(-68.8%)
-328.72%(-75.7%)
Sep 2011
-
-1353.13%(-262.5%)
Jun 2011
-
832.62%(+5.6%)
Mar 2011
-
788.69%(-193.4%)
Dec 2010
-689.29%
-844.21%(+197.3%)
DateAnnualQuarterly
Sep 2010
-
-283.92%(+45.0%)
Jun 2010
-
-195.87%(+20.5%)
Mar 2010
-
-162.53%(+49.4%)
Dec 2009
-102.12%(+118.3%)
-108.78%(+26.0%)
Sep 2009
-
-86.32%(+19.0%)
Jun 2009
-
-72.55%(+38.6%)
Mar 2009
-
-52.34%(+8.7%)
Dec 2008
-46.79%(-118.2%)
-48.15%(-2.9%)
Sep 2008
-
-49.60%(+19.7%)
Jun 2008
-
-41.42%(-131.3%)
Mar 2008
-
132.25%(-27.4%)
Dec 2007
257.55%(-103.8%)
182.09%(-37.0%)
Sep 2007
-
288.83%(-60.7%)
Jun 2007
-
735.61%(+172.0%)
Mar 2007
-
270.40%(-58.6%)
Dec 2006
-6751.38%(+5884.2%)
652.69%(-212.9%)
Sep 2006
-
-578.13%(+105.0%)
Jun 2006
-
-282.08%(+92.7%)
Mar 2006
-
-146.42%(+28.6%)
Dec 2005
-112.82%(+2.5%)
-113.88%(+16.9%)
Sep 2005
-
-97.43%(+10.4%)
Jun 2005
-
-88.28%(+27.9%)
Mar 2005
-
-69.04%(-24.0%)
Dec 2004
-110.02%(-48.4%)
-90.89%(+3.3%)
Sep 2004
-
-88.01%(-16.5%)
Jun 2004
-
-105.36%(-31.7%)
Mar 2004
-
-154.36%(-33.2%)
Dec 2003
-
-230.91%(-42.6%)
Sep 2003
-213.36%(-93.9%)
-402.57%(-75.6%)
Jun 2003
-
-1649.60%(-42.2%)
Mar 2003
-
-2851.81%(+143.4%)
Dec 2002
-
-1171.53%(+73.3%)
Sep 2002
-3486.65%(+1189.3%)
-675.85%(+57.8%)
Jun 2002
-
-428.37%(+55.4%)
Mar 2002
-
-275.71%(+29.5%)
Dec 2001
-
-212.97%(+2.9%)
Sep 2001
-270.44%(+35.3%)
-207.04%(+35.2%)
Jun 2001
-
-153.13%(+15.5%)
Mar 2001
-
-132.59%(-14.0%)
Dec 2000
-
-154.17%(+1.0%)
Sep 2000
-199.86%(-16.7%)
-152.68%(+17.4%)
Jun 2000
-
-130.04%(+51.9%)
Mar 2000
-
-85.60%(-64.0%)
Dec 1999
-
-237.68%(+91.8%)
Sep 1999
-240.00%(-205.8%)
-123.91%
Sep 1998
226.92%(-259.7%)
-
Sep 1997
-142.11%(+396.5%)
-
Sep 1996
-28.62%
-

FAQ

  • What is Imunon annual return on equity?
  • What is the all time high annual ROE for Imunon?
  • What is Imunon annual ROE year-on-year change?
  • What is Imunon quarterly return on equity?
  • What is the all time high quarterly ROE for Imunon?
  • What is Imunon quarterly ROE year-on-year change?

What is Imunon annual return on equity?

The current annual ROE of CLSN is -55.83%

What is the all time high annual ROE for Imunon?

Imunon all-time high annual return on equity is 257.55%

What is Imunon annual ROE year-on-year change?

Over the past year, CLSN annual return on equity has changed by +73.71% (+56.90%)

What is Imunon quarterly return on equity?

The current quarterly ROE of CLSN is -53.82%

What is the all time high quarterly ROE for Imunon?

Imunon all-time high quarterly return on equity is 832.62%

What is Imunon quarterly ROE year-on-year change?

Over the past year, CLSN quarterly return on equity has changed by -8.46% (-18.65%)